10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001104659-20-057436`
Period End Date	20200331
Filing Date	20200506
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	cldx-20200331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 27 Cash Flow Statement 49

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.72M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$31.53M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.31M	USD	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$53.15M	USD	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$31.00M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.11M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$1.01M	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.09M	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.30M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$66.70M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	17.73M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$55.92M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	16.97M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	16.97M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$4.12M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$4.03M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	17.73M	shares	Point-in-time
Operating Lease Right-of-Use Assets, Net	`OperatingLeaseRightOfUseAsset`	$3.74M	USD	Point-in-time
Operating Lease Right-of-Use Assets, Net	`OperatingLeaseRightOfUseAsset`	$3.47M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$48.69M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$48.69M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$41.00K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$41.00K	USD	Point-in-time
Total Assets	`Assets`	$112.50M	USD	Point-in-time
Total Assets	`Assets`	$122.93M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.17M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$1.61M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$6.50M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$5.65M	USD	Point-in-time
Current Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityCurrent`	$1.68M	USD	Point-in-time
Current Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityCurrent`	$1.94M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$1.99M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$2.03M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$10.93M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$11.64M	USD	Point-in-time
Long-Term Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityNoncurrent`	$2.11M	USD	Point-in-time
Long-Term Portion of Operating Lease Liabilities	`OperatingLeaseLiabilityNoncurrent`	$1.71M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$15.76M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$15.55M	USD	Point-in-time
Total Liabilities	`Liabilities`	$28.91M	USD	Point-in-time
Total Liabilities	`Liabilities`	$28.80M	USD	Point-in-time
Commitments and Contingent Liabilities (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at March 31, 2020 and December 31, 2019, Respectively	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at March 31, 2020 and December 31, 2019, Respectively	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 17,730,802 and 16,972,077 Shares Issued and Outstanding at March 31, 2020 and December 31, 2019, Respectively	`CommonStockValue`	$18.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 17,730,802 and 16,972,077 Shares Issued and Outstanding at March 31, 2020 and December 31, 2019, Respectively	`CommonStockValue`	$17.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$1.10B	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$1.11B	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.60M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.62M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-1.03B	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-1.01B	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$112.69M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$94.03M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$83.70M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$124.06M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$112.50M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$122.93M	USD	Point-in-time

Income Statement 27 line items

Line Item	Tag	Value	Unit	Period
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.73M	USD	1 Quarter
Total Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.43M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$11.70M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$11.15M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$4.90M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$3.67M	USD	1 Quarter
Other Asset Impairment	`OtherAssetImpairmentCharges`	$1.80M	USD	1 Quarter
Gain on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-234.00K	USD	1 Quarter
Gain on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-1.52M	USD	1 Quarter
Total Operating Expenses	`CostsAndExpenses`	$19.37M	USD	1 Quarter
Total Operating Expenses	`CostsAndExpenses`	$15.60M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-17.94M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-12.87M	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$242.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$702.00K	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-17.24M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.62M	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-0.73	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share	`EarningsPerShareBasicAndDiluted`	$-1.40	USD	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	17.41M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.30M	shares	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-17.24M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.62M	USD	1 Quarter
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$19.00K	USD	1 Quarter
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-22.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-17.22M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-12.65M	USD	1 Quarter

Cash Flow Statement 49 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-17.24M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.62M	USD	1 Quarter
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.17M	USD	1 Quarter
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.35M	USD	1 Quarter
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$63.00K	USD	1 Quarter
Amortization and Premium of Marketable Securities, Net	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$345.00K	USD	1 Quarter
Loss on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-25.00K	USD	1 Quarter
Other Asset Impairment	`OtherAssetImpairmentCharges`	$1.80M	USD	1 Quarter
Gain on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-234.00K	USD	1 Quarter
Gain on Fair Value Remeasurement of Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1`	$-1.52M	USD	1 Quarter
Stock-Based Compensation Expense	`ShareBasedCompensation`	$687.00K	USD	1 Quarter
Stock-Based Compensation Expense	`ShareBasedCompensation`	$1.69M	USD	1 Quarter
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-855.00K	USD	1 Quarter
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$93.00K	USD	1 Quarter
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-206.00K	USD	1 Quarter
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-299.00K	USD	1 Quarter
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-853.00K	USD	1 Quarter
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.46M	USD	1 Quarter
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-768.00K	USD	1 Quarter
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-1.74M	USD	1 Quarter
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.23M	USD	1 Quarter
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.11M	USD	1 Quarter
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$37.89M	USD	1 Quarter
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$22.20M	USD	1 Quarter
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$21.40M	USD	1 Quarter
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$186.00K	USD	1 Quarter
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$235.00K	USD	1 Quarter
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$21.96M	USD	1 Quarter
Net Cash Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$16.30M	USD	1 Quarter
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$1.61M	USD	1 Quarter
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$4.15M	USD	1 Quarter
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$9.00K	USD	1 Quarter
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$24.00K	USD	1 Quarter
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$4.16M	USD	1 Quarter
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$1.64M	USD	1 Quarter
Net Decrease in Cash and Cash Equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$11.49M	USD	1 Quarter
Net Decrease in Cash and Cash Equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$7.22M	USD	1 Quarter
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$22.72M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$31.53M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.31M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$22.72M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$31.53M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.23M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.31M	USD	Point-in-time
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$65.00K	USD	1 Quarter
Accrued construction in progress	`ConstructionInProgressExpendituresIncurredButNotYetPaid`	$462.00K	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.